Madison-based gene chip maker NimbleGen Systems, which in March filed for an initial public offering of stock, instead has been acquired by Swiss pharmaceutical giant Roche Holding AG in a $272.5 million deal announced today.
NimbleGen, a UW-Madison spin-off founded in 1999, had filed for a proposed IPO of up to $75 million in common stock.